ALS Center
  • Home
  • About ALS
    • About ALS
    • ALS Treatment Options
    • ALS Symptom Management
    • Frequently Asked Questions
    • Living with ALS
    • Everyday Life with ALS
  • Patient Care
    • The Clinic Experience
    • Multi Disciplinary Care
  • Research
    • Active Studies
    • Research Highlights
    • Research Teams
    • Other Resources
  • About Us
    • Our History
    • Our Team
    • News and Events
  • Donate
  • Contact
Select Page
International Workshop Focuses on Defining Prodromal Phases of ALS, FTD

International Workshop Focuses on Defining Prodromal Phases of ALS, FTD

by Michael Benatar | May 18, 2023 | Events

Michael Benatar, M.D., Ph.D., at the University of Miami organized and hosted the Second International Pre-Symptomatic ALS Workshop on February 27, 2023, which focused on defining the prodromal stages of ALS and FTD. Read the full article here.
New Grants Support Six Projects with ‘Ambitious Goal’ of Preventing ALS

New Grants Support Six Projects with ‘Ambitious Goal’ of Preventing ALS

by Michael Benatar | Feb 16, 2023 | Events

Read the full update at the link below. View update
CReATe Author Series: Ep. 3 – Dr. Michael Benatar and Neurofilament Biomarkers for ALS

CReATe Author Series: Ep. 3 – Dr. Michael Benatar and Neurofilament Biomarkers for ALS

by Michael Benatar | Dec 28, 2021 | Events, Press Releases

Dr. Michael Benatar is the Walter Bradley Chair in ALS Research, a Professor of Neurology at the University of Miami Miller School of Medicine and the Principal Investigator of the CReATe Consortium. In this interview, he will discuss the CReATe Consortium’s recent...
Pre-Symptomatic ALS Clinical Trial Paves the Way for Early Intervention Strategies in Neurodegenerative Diseases

Pre-Symptomatic ALS Clinical Trial Paves the Way for Early Intervention Strategies in Neurodegenerative Diseases

by Michael Benatar | Dec 14, 2021 | Events, Press Releases, Research Highlights

October 22, 2021 (University Of Miami press release) A groundbreaking clinical trial for unaffected individuals at risk for a genetic form of amyotrophic lateral sclerosis (ALS) could pave the way for early intervention strategies for other forms of ALS as well as a...
Learn how you can contribute to ALS research by donating CSF

Learn how you can contribute to ALS research by donating CSF

by Michael Benatar | Jul 1, 2021 | Events, Press Releases, Research Highlights

Many neurological disorders are poorly understood, in large part because researchers have few opportunities to directly study the brain and spinal cord. However, since cerebrospinal fluid (CSF), sometimes referred to simply as spinal fluid, baths the brain and spinal...
« Older Entries

Recent Posts

  • International Workshop Focuses on Defining Prodromal Phases of ALS, FTD
  • New Grants Support Six Projects with ‘Ambitious Goal’ of Preventing ALS
  • CReATe Author Series: Ep. 3 – Dr. Michael Benatar and Neurofilament Biomarkers for ALS
  • Pre-Symptomatic ALS Clinical Trial Paves the Way for Early Intervention Strategies in Neurodegenerative Diseases
  • Learn how you can contribute to ALS research by donating CSF
  • Facebook
  • Twitter
  • Google
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress